首页> 外文期刊>Cardiology >Atrial Fibrillation: Recent Advances in Understanding the Role of MicroRNAs in Atrial Remodeling with an Electrophysiological Overview
【24h】

Atrial Fibrillation: Recent Advances in Understanding the Role of MicroRNAs in Atrial Remodeling with an Electrophysiological Overview

机译:心房颤动:通过电生理学概述了解微小RNA在心房重构中的作用的最新进展。

获取原文
获取原文并翻译 | 示例
           

摘要

Atrial fibrillation (AF) is a highly prevalent condition associated with pronounced cardiovascular-related morbidity, mortality and socioeconomic burden. It accounts for more hospitalization days than does any other arrhythmia. This article reviews the basic electrophysiology of AF, electrical and structural remodeling in AF and recent advances in understanding the molecular mechanisms of AF in relation to specific microRNAs. This paper also reviews the potential role of microRNAs as novel therapeutic targets as well as biomarkers in the management of AF. AF shows characteristics typical of altered electrophysiology that promote ectopic activity and facilitate reentry, thereby contributing to the progression from short paroxysmal AF to a persistent, permanent form via atrial remodeling, even in the absence of progressive underlying heart disease. MicroRNAs have been suggested to influence the development of AF by regulating gene expression at the post-transcriptional level. Increasing evidence has identified various microRNA modifications and their impacts on AF initiation and maintenance through electrical and structural remodeling. The discovery of specific microRNAs as novel therapeutic targets and some experimental evidence implicating microRNAs as potential molecular diagnostic markers have had a significant impact on the diagnosis and management of AF and demand further research. (C) 2015 S. Karger AG, Basel
机译:心房颤动(AF)是一种高度流行的疾病,与明显的心血管相关发病率,死亡率和社会经济负担有关。它比其他任何心律不齐所占的住院天数更多。本文回顾了房颤的基本电生理,房颤的电和结构重塑,以及在了解房颤与特定microRNA相关的分子机制方面的最新进展。本文还综述了microRNA作为新型治疗靶标以及生物标志物在AF治疗中的潜在作用。 AF表现出典型的改变电生理的特征,可促进异位活动并促进折返,从而通过短暂的房颤重塑从阵发性AF演变为持久的永久性形式,即使在没有进行性基础性心脏病的情况下也是如此。有人建议通过转录后水平调控基因表达来影响AF的发展。越来越多的证据表明,各种microRNA修饰及其通过电和结构重塑对房颤引发和维持的影响。特异性microRNAs作为新型治疗靶标的发现以及一些实验证据表明microRNAs作为潜在的分子诊断标志物已对房颤的诊断和治疗产生了重大影响,需要进一步研究。 (C)2015 S.Karger AG,巴塞尔

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号